Samit Hirawat
Vermögen: 2 Mio $ am 31.08.2026
Vermögen: 2 Mio $ am 31.08.2026
Dr. Samit Hirawat, MD, is an Independent Director at Pacira Biosciences, Inc. and an Operating Partner at Jeito Capital /US/.
He is on the Board of Directors at Pacira Biosciences, Inc. Dr. Hirawat was previously employed as a Chief Medical Officer, EVP & Head-Development by Bristol Myers Squibb Co. and a Head- Global Oncology Development by Novartis AG.
He received his undergraduate degree from SMS Medical College & Hospital.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.03.2026 | 31’925 ( 0% ) | 2 Mio $ | 31.08.2026 | |
| 10.06.2026 | 6’405 ( 0.02% ) | 165 890 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 27.01.2026 |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Direktor/Vorstandsmitglied | 01.08.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2025 |
| NOVARTIS AG | Corporate Officer/Principal | 01.06.2019 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pacira Biosciences, Inc.
Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
SMS Medical College & Hospital
SMS Medical College & Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen